Anti-human folate receptor beta antibodies and methods of use

Compositions and methods for treating IgE-mediated disorders

Humanized anti-human CD34 monoclonal antibody and uses thereof

Human anti-B7RP1 neutralizing antibodies

Anti-human epidermal growth factor receptor antibody and uses thereof

Anti-CD38 antibodies

Proteins that bind PI16 and uses thereof

Antibodies to MUC16 and methods of use thereof

Anti-ANGPTL3 antibodies and uses thereof

Monoclonal antibodies against HER2 epitope

Immunobinders directed against sclerostin

Anti-human transferrin receptor antibody and uses thereof

LLT-1 antibodies with new functional properties

VEGF/DLL4 binding agents and uses thereof

Deimmunized anti c-Met humanized antibodies and uses thereof

Immunobinders directed against TNF

Antibodies against human angiopoietin 2

Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same

Antigen binding proteins

Binding molecules for BCMA and CD3

Binding molecules for BCMA and CD3

Anti-TAT226 antibodies and immunoconjugates

Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies

Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof

Anti-VEGF antibody compositions and methods

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

RNF8-FHA domain-modified protein and method of producing the same

Anti-EphrinB2 antibodies and methods using same

Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof

Biological materials related to HER3

Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II

Humanized antibodies to iNKT

Interferon lambada-antibody complexes

Highly-functional mutant of humanized anti-EGFR antibody variable region

Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders

Antibodies, kit and method for detecting amyloid beta oligomers

Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof

Anti-serum albumin binding variants

Anti-HtrA1 antibodies and methods of use

Antibodies to the C3d fragment of complement component 3

Human FGF receptor and β-Klotho binding proteins

Methods for treating cancer by administering an anti-Ang-2 antibody

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases

Antibodies specific for Trop-2 and their uses

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies

Antibody variants with enhanced complement activity

Sclerostin binding antibodies

Humanized anti-CD19 antibodies

Heterodimeric proteins and methods for producing and purifying them

Anti-IL-23 heterodimer specific antibodies

Optical dome bezel

Antibodies to human programmed death receptor PD-1

Antibodies to human programmed death receptor PD-1

Method of detection of neutralizing anti-actriib antibodies

Antikine antibodies that bind to multiple CC chemokines

Antagonist antibodies against EphB3

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

Humanized PcrV antibody having anti-pseudomonal activity

Human antibody drug conjugates against tissue factor

Antibodies directed against nerve growth factor (NGF)

Antagonists of IL-6 to prevent or treat thrombosis

Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)

Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cell

SPARC binding antibodies and uses thereof

Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand

Anti-A(β) oligomer humanized antibody

Antibody polypeptides that antagonize CD40L

Anti-FZD10 monoclonal antibodies and methods for their use

PD-1 antibody

Anti-α5β1 antibodies and uses thereof

Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors

Anti-human TROP-2 antibody having anti-tumor activity in vivo

Binding members for human cytomegalovirus

Antibody specifically binding to epitope in SEMA domain of c-Met

Anti c-Met humanized antibody and uses thereof

Antibodies directed to ERBB2

ANTI C-MET ANTIBODY AND USES THEREOF

Antibodies with enhanced or suppressed effector function

Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42

Anti-FcRH5 antibodies and immunoconjugates and methods of use

RECOMBINANT RENEWABLE POLYCLONAL ANTIBODIES

Anti-ErbB3 antibodies and uses thereof

Anti-MCSP antibodies

Bispecific binding molecules binding to VEGF and ANG2

4-1BB binding molecules

CD27L antigen binding proteins

Anti-C5 alpha antibodies

Human CGRP Receptor Binding Proteins

Antibodies to PCSK9 and uses thereof

1B20 PCSK9 antagonists

Compositions and methods for antibodies targeting complement protein C5

METHODS FOR TREATING HYPERCHOLESTEROLEMIA USING ANTIBODIES TO PCSK9

METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS

Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies

Humanized anti-EGFL7 antibodies and methods using same

Nucleic acids encoding engineered anti-IL-23R antibodies

Anti-ICAM-1 single domain antibody and uses thereof

Method for treating Crohn's disease by administering an anti-IL-12 antibody

Development of masked therapeutic antibodies to limit off-target effects

Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin

ANTI-IGA1 ANTIBODY

Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein

Anti-polyubiquitin antibodies

Anti-HSV antibody

Antagonists of IL-6 to prevent or treat thrombosis

Antibodies Directed To Gpnmb And Uses Thereof

Novel Modulators and Methods of Use

Antigenic GM-CSF peptides and antibodies to GM-CSF

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

BOVINE POLYCLONAL ANTIBODY SPECIFIC FOR HUMAN TNF

Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases

Bispecific antigen binding molecules

Antibodies to tumor endothelial marker 7R

Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies

ANTI-VEGF ANTIBODIES

Optimized fc variants and methods for their generation

Multivalent Antibodies

Antibody against human TSH and canine TSH

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)

Fully human monoclonal antibody to VEGF, preparation method and use thereof

Anti-FGFR3 antibodies and methods using same

BINDING DOMAINS

Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain

Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof

FC RECEPTOR BINDING PROTEINS

ANTI-PD-L1 ANTIBODIES AND ARTICLES OF MANUFACTURE

METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY

METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO TREAT INFECTION RESULTING FROM T-CELL DYSFUNCTION

Biologic female contraceptives

Transgenic mouse homozygous for chimeric IgH locus

SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

Antigen associated with the neovasculature of tumour metastases

Monoclonal antibody against necrosis marker ERP29 and use thereof

ANTI-MUC1 ANTIBODIES FOR CANCER DIAGNOSTICS

Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof

HUMAN ANTIBODIES AGAINST RABIES AND USES THEREOF

Antibodies that inhibit metalloproteins

Anti-EFGRv3 monoclonal antibody

Engineered anti-IL-23p19 antibodies

Heterodimeric antibody Fc-containing proteins and methods for production thereof

Methods of treatment using IL-18 receptor antigen binding proteins

Anti-RSV G protein antibodies

Targeted binding agents against B7-H1

Subcutaneously administrable composition containing anti-IL-6 antibody

Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers

TREATMENT OF TRAUMATIC BRAIN INJURY USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

Class I anti-CEA antibodies and uses thereof

Anti-activin a antibodies and uses thereof

Rodent combinatorial antibody libraries

Antibodies to the NOTCH1 receptor

Nucleic acid encoding IL-7 receptor alpha antibody

Human antibodies that bind mesothelin, and uses thereof

Human antibodies that bind mesothelin, and uses thereof

Human antibodies that bind mesothelin, and uses thereof

Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity

Expandable liquid volume in an LED bulb

ANTIBODIES TO CD40

Antibodies to matrix metalloproteinase 9

Humanization of rabbit antibodies using a universal antibody framework

Antibody to peptide

Anti-epidermal growth factor receptor antibodies and uses thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Interleukin-31 monoclonal antibody

Compositions and Methods for Antibodies Targeting Complement Protein C5

Antagonists against TNFR1 and methods of use therefor

Dual Specific Immunotoxin for Brain Tumor Therapy

METHODS OF PRODUCING HYBRIDOMAS AND MONOCLONAL ANTIBODIES AND ANTIBODIES PRODUCED THEREBY

Single variable domain antibodies against OX40L, constructs and therapeutic use

Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity

Nucleic acid molecules encoding A-beta binding polypeptides

Anti-IL-6 antibodies

Anti-folate receptor alpha antibodies and uses thereof

Multivalent fibronectin based scaffold domain proteins

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

Antibody-drug conjugates

Antibodies to lymphotoxin-alpha

Antagonist anti-CD40 monoclonal antibodies and methods for their use

Active protease-resistant antibody FC mutants

Antibodies against human CSF-1R

Nucleic acid encoding antibody to human IL-22

Anti-C5a receptor antibodies

Engineered anti-TSLP antibody

Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses

Engineered anti-TSLP antibody

Human IL-23 antigen binding proteins

ANTI-NGF ANTIBODIES FOR THE TREATMENT OF VARIOUS DISORDERS

TREATMENT OF VASCULARIZED PIGMENT EPITHELIAL DETACHMENT WITH ANTI-VEGF THERAPY

Humanized and chimeric anti-properdin antibodies

Antibodies against human CSF-1R

Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

Lowered affinity antibodies and methods of making the same

METHODS OF IDENTIFYING OBM MODULATORS

Anti-CD22 antibodies and immunoconjugates and methods of use

Polynucleotides encoding antibodies that bind both IL-17A and IL-17F

Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof

ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS

Targeted binding agents directed to sonic hedgehog homolog and uses thereof

Trispecific Therapeutics Against Acute Myeloid Leukaemia

Polynucleotides encoding humanized anti-factor D antibodies

Monoclonal antibody against necrosis marker PRDX4 and use thereof

Anti-GD2 antibodies

FOXO6 POLYCLONAL ANTIBODY AND METHOD FOR PREPARING THE SAME

Anti-VEGF antibodies

ADAM6 mice

Anti-epidermal growth factor receptor antibodies and uses thereof

Methods of treating gout using IL-1BETA antibodies

Method for detecting erythropoietin (EPO) receptor using anti-human EPO receptor antibodies

Antibodies against G-CSFR and uses thereof

Methods and compositions for inhibiting CD32B expressing cells

ANTI-C4.4A ANTIBODIES AND USES THEREOF

Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)

Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)

Antibodies to c-Met

CRYSTAL STRUCTURES AND METHODS USING SAME

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

Disulfide Stabilised Multivalent Antibodies

METHODS FOR AFFINITY MATURATION-BASED ANTIBODY OPTIMIZATION

Antibodies specific for TGF-beta and methods for treating thereof

Compositions and Methods for the Therapy and Diagnosis of Influenza

IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS

Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)

Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies

Human monoclonal antibody that specifically binds to VCAM-1 and a composition for treating an inflammatory disease or a cancer comprising the same

Anti-IL-23 antibodies

USE OF IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS

Methods of using antibodies that bind the glutamate ligand binding region of Notch1

BIOLOGICAL PRODUCTS

COILED COIL AND/OR TETHER CONTAINING PROTEIN COMPLEXES AND USES THEREOF

Jagged-binding agents and uses thereof

Anti-CD40 antibodies

Anti-C5/C5a antibodies and methods of use

Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections

ANTI-MN ANTIBODIES AND METHODS OF USING SAME

Compounds

1D05 PCSK9 antagonists

DAC HYP COMPOSITIONS AND METHODS

Meditopes and meditope-binding antibodies and uses thereof

NUCLEIC ACIDS ENCODING ANTI-IL-23 ANTIBODIES

Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof

Endoglin antibodies

Antagonists of IL-17A, IL-17F, and IL-23P19

FGFR1 agonists and methods of use

ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP

Ganglioside epitopes for treating Guillain-Barre syndrome

Anti-TEM1 antibodies and uses thereof

Antibodies against clostridium difficile toxins and uses thereof

c-Kit antibodies and uses thereof

Antagonists of IL-6 to prevent or treat thrombosis

Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120

Human monoclonal antibodies to BTLA and methods of use

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCER

Methods of treatment by administering antibodies to notch receptors

Multivalent Antibodies

Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides

POLYPEPTIDES FOR BINDING TO THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS AS WELL AS COMPOSITIONS AND METHODS INVOLVING

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Bi-specific digoxigenin binding antibodies

Anti P2X7 receptor antibodies and fragments thereof

Formulation of human antibodies for treating TNF-α associated disorders

Anti-IL-23 antibodies

Neutralizing antibodies to HIV-1 and their use

Compositions for inhibiting MASP-2 dependent complement activation

CD127 binding proteins

Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

ANTIBODIES AND CONJUGATES FOR MODULATORS OF ANGIOGENESIS

Inhibition of the interaction between 5T4 oncofoetal glycoproteins and CXC chemokine receptors as a method of identifying chemotaxis inhibitors

Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT

Anti-TNF antibodies, compositions, methods and uses

Multivalent Immunoglobulin-Based Bioactive Assemblies

Polynucleotides encoding antibodies against sclerostin and uses therefor

Immunoconjugates

Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof

Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

Polynucleotides encoding anti-factor XI monoclonal antibodies and methods of use thereof

MULTISPECIFIC MODULAR ANTIBODY

METHODS OF TREATMENT UTILIZIING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR

Identification and engineering of antibodies with variant Fc regions and methods of using same

Anti ganglioside GD3 antibodies and uses thereof

Pharmaceutical composition

IL-1 Binding Proteins

Transgenic animals expressing chimeric antibodies for use in preparing human antibodies

FLUOROIMMUNOASSAY METHOD

Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof

Methods of obtaining a specific binding member that binds eotaxin

Compositions relating to a mutant toxin and methods thereof

HIV-1 ANTIBODIES

Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies

Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor

ANTI-C MPL ANTIBODIES

Bispecific anti-IGF-1R and anti-ErbB3 antibodies

Compositions and methods for blood-brain barrier delivery of IgG-decoy receptor fusion proteins

Antibodies directed against amyloid-beta peptide and methods using same

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

Human antibodies specifically binding to the hepatitis B virus surface antigen